OCT-Guided Stent Implantation, IVUS, and Angiography-Guided PCI Compared
By MedImaging International staff writers Posted on 04 Sep 2015 |
A medical device vendor has announced the launch of a clinical study to compare intravascular assessments and Percutaneous Coronary Intervention (PCI) during stent implantation, using guidance by Optical Coherence Tomography (OCT), Intravascular Ultrasound (IVUS) or only angiography.
The ILUMIEN III multicenter randomized study is intended to improve the standard of care for cardiovascular patients by using OCT technology to enable clinicians to provide anatomical images of disease morphology, and automatically measure vessel characteristics that are difficult to assess using IVUS or angiography. The measurements are needed for stent selection, stent deployment, and placement, and can decrease the risk of repeated revascularization.
The OCT technique was developed by St. Jude Medical (St. Paul, MN, USA). Clinicians will use St. Jude’s Optis Integrated and ILUMIEN Optis PCI optimization systems for the study. The study will include up to 420 patients from Europe, the US, and Japan.
Clinicians use diagnostic imaging during PCI procedures to decide on the size of the required stent, and increase the minimal stent area (MSA). This revascularization procedure ensures that the stent expands enough during PCI to restore blood flow.
Dr. Mark Carlson, chief medical officer at St. Jude Medical, said, “The launch of ILUMIEN III is an important step in assessing St. Jude Medical’s OCT technology and its ability to improve stent implantation over first generation diagnostic tools. The study builds on important research showing the benefits of OCT imaging in supporting clinical decision making, and we’re excited to have this important trial underway.”
Related Links:
St. Jude Medical
The ILUMIEN III multicenter randomized study is intended to improve the standard of care for cardiovascular patients by using OCT technology to enable clinicians to provide anatomical images of disease morphology, and automatically measure vessel characteristics that are difficult to assess using IVUS or angiography. The measurements are needed for stent selection, stent deployment, and placement, and can decrease the risk of repeated revascularization.
The OCT technique was developed by St. Jude Medical (St. Paul, MN, USA). Clinicians will use St. Jude’s Optis Integrated and ILUMIEN Optis PCI optimization systems for the study. The study will include up to 420 patients from Europe, the US, and Japan.
Clinicians use diagnostic imaging during PCI procedures to decide on the size of the required stent, and increase the minimal stent area (MSA). This revascularization procedure ensures that the stent expands enough during PCI to restore blood flow.
Dr. Mark Carlson, chief medical officer at St. Jude Medical, said, “The launch of ILUMIEN III is an important step in assessing St. Jude Medical’s OCT technology and its ability to improve stent implantation over first generation diagnostic tools. The study builds on important research showing the benefits of OCT imaging in supporting clinical decision making, and we’re excited to have this important trial underway.”
Related Links:
St. Jude Medical
Latest Ultrasound News
- Diagnostic System Automatically Analyzes TTE Images to Identify Congenital Heart Disease
- Super-Resolution Imaging Technique Could Improve Evaluation of Cardiac Conditions
- First AI-Powered POC Ultrasound Diagnostic Solution Helps Prioritize Cases Based On Severity
- Largest Model Trained On Echocardiography Images Assesses Heart Structure and Function
- Groundbreaking Technology Enables Precise, Automatic Measurement of Peripheral Blood Vessels
- Deep Learning Advances Super-Resolution Ultrasound Imaging
- Novel Ultrasound-Launched Targeted Nanoparticle Eliminates Biofilm and Bacterial Infection
- AI-Guided Ultrasound System Enables Rapid Assessments of DVT
- Focused Ultrasound Technique Gets Quality Assurance Protocol
- AI-Guided Handheld Ultrasound System Helps Capture Diagnostic-Quality Cardiac Images
- Non-Invasive Ultrasound Imaging Device Diagnoses Risk of Chronic Kidney Disease
- Wearable Ultrasound Platform Paves Way for 24/7 Blood Pressure Monitoring On the Wrist
- Diagnostic Ultrasound Enhancing Agent to Improve Image Quality in Pediatric Heart Patients
- AI Detects COVID-19 in Lung Ultrasound Images
- New Ultrasound Technology to Revolutionize Respiratory Disease Diagnoses
- Dynamic Contrast-Enhanced Ultrasound Highly Useful For Interventions